X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercepharma.com/pharma/seagen-astellas-and-mercks-padcev-keytruda-combo-scores-big-practice-changing-first-line
https://www.fiercebiotech.com/biotech/taysha-ends-work-gene-therapy-after-astellas-walks-away-fda-requests-randomized-trial
https://www.fiercepharma.com/pharma/astellas-says-24-month-trial-izervay-met-its-primary-objective-reveals-little-else
https://www.prnewswire.com/news-releases/astellas-venture-management-and-mbc-biolabs-announce-the-5th-annual-astellas-future-innovator-prize-301929672.html
https://www.prnewswire.com/news-releases/astellas-highlights-veozah-fezolinetant-data-at-the-2023-annual-meeting-of-the-menopause-society-301929731.html
https://www.prnewswire.com/news-releases/astellas-to-invest-more-than-330-million-in-a-new-state-of-the-art-facility-in-tralee-co-kerry-ireland-301927285.html
https://www.prnewswire.com/news-releases/menarini-asia-pacific-enters-into-an-exclusive-licensing-agreement-with-astellas-to-commercialize-smyraf-in-taiwan-and-select-south-east-asian-markets-301925637.html
https://www.prnewswire.com/news-releases/european-medicines-agency-validates-type-ii-variation-for-astellas-xtandi-enzalutamide-for-treatment-of-non-metastatic-hormone-sensitive-prostate-cancer-with-high-risk-biochemical-recurrence-301925285.html
https://www.reuters.com/article/health-usa-drugpricing-astellas-pharma/astellas-withdraws-lawsuit-challenging-medicare-drug-price-negotiation-plans-idUKL4N3AI3X0
https://www.globenewswire.com/news-release/2023/08/28/2732288/0/en/Sandoz-completes-acquisition-of-leading-antifungal-agent-Mycamine-from-Astellas-reinforcing-leading-global-anti-infectives-portfolio.html
Market Place
Share 
